| MAS1 oncogene | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | MAS1 | ||||||
| NCBI gene | 4142 | ||||||
| HGNC | 6899 | ||||||
| OMIM | 165180 | ||||||
| RefSeq | NM_002377 | ||||||
| UniProt | P04201 | ||||||
| Other data | |||||||
| Locus | Chr. 6q24-q27 | ||||||
| |||||||
| MAS1 oncogene-like | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | MAS1L | ||||||
| NCBI gene | 116511 | ||||||
| HGNC | 13961 | ||||||
| OMIM | 607235 | ||||||
| RefSeq | NM_052967 | ||||||
| UniProt | P35410 | ||||||
| Other data | |||||||
| Locus | Chr. 6p21 | ||||||
| |||||||
TheMAS1 oncogene (MAS receptor) is aG protein-coupled receptor[1][2] which binds theangiotensin II metaboliteangiotensin (1-7).[3][4] The MAS1 receptor, when activated by binding angiotensin-(1-7), opposes many of the effects of theangiotensin II receptor. Hence, MAS1 receptoragonists have similar therapeutic effects toangiotensin II receptor antagonists, including lowering of blood pressure.[5]
(2) a counter-regulatory or vasodilator pathway comprising angiotensin-converting enzyme 2 (ACE2), Angiotensin-(1-7) [Ang-(1-7)] and Mas receptor, which is involved in vasodilation, antiproliferation, anti-hypertrophy, cardioprotective and renoprotective actions.
Thismembrane protein–related article is astub. You can help Wikipedia byexpanding it. |